Media coverage
1
Media coverage
Title FDA Accepts BrainStorm's NurOwn® IND Application for Progressive Multiple Sclerosis; U.S. Phase 2 Study to Begin in First Quarter of 2019 Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 17/12/18 Persons Fred Lublin